TULANE CANCER GENETICS COBRE: INOVATIVE THERAPIES FOR T(4;11) LEUKEMIA

杜兰大学癌症遗传学 COBRE：T(4;11) 白血病的创新疗法

• 批准号: 7171363
• 负责人: Charles Stanley Hemenway
• 金额: $ 28.57万
• 依托单位: TULANE UNIVERSITY OF LOUISIANA
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-08-01 至 2006-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7171363
• 关键词: genetic regulation; neoplasm /cancer genetics

DESCRIPTION (provided by applicant): This COBRE is designed to develop the research careers of a series of promising junior investigators in the field of Cancer Genetics. Their careers will be developed utilizing a strong core of research mentors who will help craft a plan for the development of each investigator, and provide advice and encouragement to those investigators. The five projects in this COBRE focus on two critical, overlapping areas in cancer genetics, genetic instability and gene regulation. An internal advisory committee composed of mentors and other scientists with extremely strong research and mentoring records, along with a prominent board of external advisors with outstanding research careers and track records of career development for junior scientists, will participate not only in the guidance, but also the evaluation of progress of the junior investigators. Besides the strong mentoring program, career development will involve a series of program meetings, exposure to didactic grant-writing sessions, mini-symposia, and seminars to develop a highly collaborative environment for both the junior faculty, as well as other members of the COBRE and the Cancer Genetics Research Program under the auspices of the Louisiana Cancer Research Consortium (LCRC). The LCRC is a joint effort of Tulane University and the Louisiana State University Health Sciences Center in New Orleans to develop a Cancer Consortium. The Consortium is funded by a long-term State of Louisiana commitment, with the goal of obtaining NCI-designation for a Cancer Center in New Orleans. The Consortium is providing funds for recruitment of at least 6 new investigators for the Cancer Genetics Research Program in the next two years, as well as providing a new building that will allow investigators from both Tulane and LSUHSC to share common space designed around this Program. This COBRE will represent the ideal centerpiece to develop successful and productive careers of promising junior investigators who are valuable members of the Cancer Genetics Research Program, in a manner centered on collaboration and faculty development, resulting in strong growth and establishing long-term success of both the COBRE and the Cancer Genetics Research Program.

描述（由申请人提供）： 该 COBRE 旨在发展癌症遗传学领域一系列有前途的初级研究人员的研究生涯。他们的职业生涯将利用强大的研究导师核心来发展，这些导师将帮助为每位研究者的发展制定计划，并为这些研究者提供建议和鼓励。 COBRE 的五个项目重点关注癌症遗传学、遗传不稳定性和基因调控两个关键的、重叠的领域。由具有极强研究和指导记录的导师和其他科学家组成的内部顾问委员会，以及具有杰出研究生涯和青年科学家职业发展记录的杰出外部顾问委员会，不仅将参与指导，而且还将参与对青年研究人员进展的评估。除了强有力的指导计划外，职业发展还将涉及一系列计划会议、参与教学资助写作会议、小型研讨会和研讨会，以便为初级教师以及路易斯安那州癌症研究联盟 (LCRC) 赞助下的 COBRE 和癌症遗传学研究计划的其他成员创造一个高度协作的环境。 LCRC 是杜兰大学和新奥尔良路易斯安那州立大学健康科学中心共同努力建立的癌症联盟。该联盟由路易斯安那州长期承诺资助，目标是为新奥尔良癌症中心获得 NCI 指定。该联盟将提供资金，在未来两年内为癌症遗传学研究项目招募至少 6 名新研究人员，并提供一座新大楼，让杜兰大学和路易斯安那州立大学医学中心的研究人员共享围绕该项目设计的公共空间。该 COBRE 将成为有前途的初级研究人员发展成功和富有成效的职业生涯的理想核心，这些初级研究人员是癌症遗传学研究计划的重要成员，以合作和教师发展为中心，从而实现 COBRE 和癌症遗传学研究计划的强劲增长并建立长期成功。